This week we’ve highlighted the White House’s strategy to address future pandemics, President Biden’s executive order on lowering prescription drug costs, the availability and reduced pricing of hearing aids, and the Food and Drug Administration’s updated authorization for Moderna and Pfizer-BioNTech ... READ MORE >
drug pricing
5 things to know in life sciences: Week of March 21, 2022
This week we highlight continued investment in virtual trials, robotic injections, costs of COVID-19 treatments and the need to understand drug safety for pregnant patients. Finally, we look at the most recent round of drug pricing reform in Congress which aims to reduce insulin prices. Each week we ... READ MORE >
5 things to know in life sciences: Week of November 1
The life sciences industry saw the first meaningful activity around drug pricing reform as Democratic lawmakers included language in their domestic spending package. At the same time, innovation and investment continue to exemplify the life sciences ecosystem. By the way, we’re a little late in getting ... READ MORE >
5 things to know in life sciences: Week of August 9
With eyes on infrastructure policymaking this week, our roundup takes a look at the components of the Democrats' $3.5 trillion budget framework that could affect the life sciences industry. We also highlight a major investment in surgical robotics, the performance of companies post-merger with a special ... READ MORE >
Drug pricing and health care innovation could benefit from Biden’s latest executive order
On July 9, President Biden issued an executive order on promoting competition in the American economy that could have significant ramifications for health care systems. The order indicates that the pace of business consolidation has accelerated and that “in over 75% of U.S. industries, a smaller number ... READ MORE >
5 things to know in life sciences: Week of May 24
Over the past year, there has been a simmering dispute between hospitals and pharmaceutical companies over the 340B drug pricing program. This week, the United States Department of Health and Human Services weighed in strongly on the side of the hospitals. We also look at the discussion at the World Trade ... READ MORE >
5 things to know in life sciences: Week of March 22
In this week’s life sciences roundup: the AstraZeneca-Oxford COVID-19 vaccine has faced challenging headwinds in the past week as several European Union countries paused distribution pending additional information from the European Medicines Agency, and as the National Institute of Allergy and Infectious ... READ MORE >
5 things to know in life sciences: Week of Feb. 8
In this week’s roundup, we look at the impact of new COVID-19 variants on existing vaccines for the disease; South Africa made the difficult decision to stop using its most readily available vaccine after it showed limited effectiveness against the variant most common there. This is an important ... READ MORE >
5 things to know in life sciences: Week of Jan. 25
This week’s roundup includes several reads about a crucial but often unnoticed shift in the life sciences ecosystem—the interplay between the digital future of life science, the development of next generation therapeutics, and the promise of personalized medicine. The drop in cost and increase in ... READ MORE >